Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 32Phase NA 15Phase 3 15Phase 1/2 14Phase 2/3 3Phase 4 1

Status

Recruiting 4Completed 4Unknown 3Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Thoracic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Injections × Clear all
NCT04209868 2024-03-29

ParaSOL

Guy's and St Thomas' NHS Foundation Trust

Phase 2/3 Unknown
100 enrolled
Thoracic

Thoracic Neoplasms

NCT04924699 2023-03-17

A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer

Shanghai Miracogen Inc.

Phase 2/3 Unknown
350 enrolled
Breast

Breast Neoplasms

NCT05280444 2022-12-29

Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Zhongda Hospital

Phase 2/3 Unknown
216 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡